Search This Blog

Friday, November 20, 2026

Cognitive-Behavioral Therapy Effective for Chronic Insomnia

 Cognitive- behavioral therapy (CBT) is safer and more effective than sleep medications for chronic insomnia and is now readily available through self-guided apps, according to a presentation delivered at the Family Medicine Forum (FMF) 2026.

Healthcare providers should wean patients from sleep medications such as sedatives when they are no longer needed, David Gardner, PharmD, professor of psychiatry at Dalhousie University in Halifax, told Medscape News Canada. "Now is the time for us to be all together on this, to be a part of the transformation of insomnia management from pharmacologic to nonpharmacologic approaches."

Patients with sleep complaints are advised to practice sleep hygiene by, for example, avoiding devices before bedtime and maintaining a dark environment in the bedroom. But while these techniques might work for short-term insomnia, they typically don't significantly affect chronic insomnia, said Gardner. Chronic insomnia is defined as difficulty initiating or maintaining sleep on at least three nights per week for 3 or more months.

Setting a regular bedtime and rise time and using the bed only for sleep, sickness, and sex can help manage severe insomnia. But CBT for insomnia (CBT-I),an evidence-based 4- to 8-week program that involves cognitive and behavioral strategies, is effective, said Gardner. Patients learn to adapt their habits and change thought patterns that interfere with a good night's sleep.

Reducing Medications 

Although CBT-I used to be available only through trained therapists, it's increasingly accessible. Gardner suggests that physicians and patients examine the nonprofit Sleepwell program, a "one-stop shop" to learn what self-guided apps and programs are available. Sleepwell's main goals are to help patients with insomnia improve their sleep and stop taking sleeping pills safely and effectively, according to its website. 

It's important to find an effective alternative to sleep medications, prescriptions that increase steadily as patients get older, especially when they reach their eighties and nineties, said Gardner. "That's where we really have concerns because of the vulnerability to the side effects, which are greatest in older, frailer adults."

The risks of pharmaceutical sleep aids include falls, fractures, cognitive impairment, and flu-related pneumonia that results from these agents' effects on the immune system. Moreover, drugs don't treat the underlying cause of chronic insomnia, said Gardner.

Researchers have compared the benzodiazepine temazepam with placebo, said Stephanie Lynch, PharmD, a pharmacist and research lead at Queen's University in Belleville-Quinte, Ontario. With the medication, the time to sleep initiation was 11 minutes shorter according to polysomnography and 7 minutes shorter according to self-assessment. The medication also was associated with 21 more minutes of sleep.

To reduce patients' reliance on sleep aids, clinicians could avoid prescribing them to begin with, avoid dose escalations, and deprescribe the medications, said Lynch. The latter technique could involve conversations with patients about why they take the sleep aid, how effective they think it is, and whether they experience related side effects, she added.

The Default Option 

A sleep diary can be useful for managing insomnia. It can document sleep timing and track overnight awakenings, daytime naps, and use of alcohol, cannabis, and sleep medications.

CBT-I should be the default option for patients with severe insomnia, Guylène Thériault, MD, a family doctor in Gatineau, Quebec, told Medscape News Canada. Research shows that the number needed to treat with CBT-I is three. "I have to offer CBT-I to three patients for one of them to have success, which is huge" and better than a pharmaceutical treatment, said Thériault.

Thériault, who has been practicing for 30 years, didn't learn about CBT-I in medical school and welcomes the expanding number of resources that are available for patients. In addition to Sleepwell, other useful resources can be found at the Canadian Medication Appropriateness and Deprescribing Network and Choosing Wisely Canada, she noted. Doctors can find patient handouts and deprescribing schedules on these sites.

She recognizes that it's difficult to "just switch patients to CBT-I" if they have been taking benzodiazepines for a lengthy period. "But it's something that should be discussed with patients."

Sleepwell receives funding from the Drug Evaluation Alliance of Nova Scotia and the government of Nova Scotia. Gardner and Lynch reported no relevant financial relationships. Thériault reported receiving an honorarium from Choosing Wisely Canada.

https://www.medscape.com/viewarticle/cognitive-behavioral-therapy-effective-chronic-insomnia-2026a10019ap

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.